Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet

被引:125
作者
Merat, S [1 ]
Casanada, F [1 ]
Sutphin, M [1 ]
Palinski, W [1 ]
Reaven, PD [1 ]
机构
[1] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
关键词
arteriosclerosis; diabetes; fructose; hypercholesterolemia; lipoproteins;
D O I
10.1161/01.ATV.19.5.1223
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The role of insulin resistance (IR) in atherogenesis is poorly understood, in part because of a lack of appropriate animal models. We assumed that fructose-fed LDL receptor-deficient (LDLR-/-) mice might be a model of IR and atherosclerosis because (1) fructose feeding induces hyperinsulinemia and IR in rats; (2) a preliminary experiment showed that fructose feeding markedly increases plasma cholesterol levels in LDLR-/- mice; and (3) hypercholesterolemic LDLR-/- mice develop extensive atherosclerosis. To test whether IR could be induced in LDLR-/- mice, 3 groups of male mice were fed a fructose-rich diet (60% of total calories; n=16), a fat-enriched (Western) diet intended to yield the same plasma cholesterol levels (n=18), or regular chow (n=7) for approximately 5.5 months. The average cholesterol levels of both hypercholesterolemic groups were similar (849+/-268 versus 964+/-234 mg/dL) and much higher than in the chow-fed group (249+/-21 mg/dL). Final body weights in the Western diet group were higher (39+/-6.2 g) than in the fructose- (27.8+/-2.7 g) or chow-fed (26.7+/-3.8 g) groups. Contrary to expectation, IR was induced in mice fed the Western diet, but not in fructose-fed mice. The Western diet group had higher average glucose levels (187+/-16 versus 159+/-12 mg/dL) and 4.5-fold higher plasma insulin levels. Surprisingly, the non-insulin-resistant, fructose-fed mice had significantly more atherosclerosis than the insulin-resistant mice fed Western diet (11.8+/-2.9% versus 7.8+/-2.5% of aortic surface; P<0.01). These results suggest that (1) fructose-enriched diets do not induce IR in LDLR-/- mice; (2) the Western diets commonly used in LDLR-/- mice may not only induce atherosclerosis, but also IR, potentially complicating the interpretation of results; and (3) IR and hyperinsulinemia do not enhance atherosclerosis in LDLR-/- mice, at least under conditions of very high plasma cholesterol levels. The fact that various levels of hypercholesterolemia can be induced in LDLR-/- mice by fat-enriched diets and that such diets induce IR and hyperinsulinemia suggest that LDLR-/- mice may be used as models to elucidate the effect of IR on atherosclerosis, eg, by feeding them Western diets with or without insulin-sensitizing agents.
引用
收藏
页码:1223 / 1230
页数:8
相关论文
共 64 条
[1]   Hyperinsulinaemia accelerates accumulation of cholesterol ester in aorta of rats with transplanted pancreas [J].
Abe, H ;
Bandai, A ;
Makuuchi, M ;
Idezuki, Y ;
Nozawa, M ;
Oka, T ;
Osuga, J ;
Watanabe, Y ;
Inaba, T ;
Yamada, N .
DIABETOLOGIA, 1996, 39 (11) :1276-1283
[2]   INSULIN, INSULIN-LIKE GROWTH FACTOR-I AND PLATELET-DERIVED GROWTH-FACTOR INTERACT ADDITIVELY IN THE INDUCTION OF THE PROTOONCOGENE C-MYC AND CELLULAR PROLIFERATION IN CULTURED BOVINE AORTIC SMOOTH-MUSCLE CELLS [J].
BANSKOTA, NK ;
TAUB, R ;
ZELLNER, K ;
KING, GL .
MOLECULAR ENDOCRINOLOGY, 1989, 3 (08) :1183-1190
[3]   ROLE OF OXIDATIVE STRESS IN DEVELOPMENT OF COMPLICATIONS IN DIABETES [J].
BAYNES, JW .
DIABETES, 1991, 40 (04) :405-412
[4]  
Bird DA, 1998, J LIPID RES, V39, P1079
[5]   Body fat distribution, insulin resistance, and metabolic diseases [J].
Bjorntorp, P .
NUTRITION, 1997, 13 (09) :795-803
[6]   Dietary rat models in which the development of hypertriglyceridemia and that of insulin resistance are dissociated [J].
Boivin, A ;
Deshaies, Y .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (12) :1540-1547
[7]   LILLY LECTURE 1993 - GLYCATION AND DIABETIC COMPLICATIONS [J].
BROWNLEE, M .
DIABETES, 1994, 43 (06) :836-841
[8]  
BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315
[9]  
CANTAFORA A, 1993, P SOC EXP BIOL MED, V204, P90, DOI 10.3181/00379727-204-43639
[10]  
COLEMAN DL, 1982, DIABETES, V31, P1